Exercise helps to improve the severity of the movement-related symptoms and the overall well-being of those suffering from Parkinson's disease.
Focused ultrasound treatments help to improve motor symptoms associated with Parkinson's disease and dyskinesia.
Using AI, researchers identified Probucol, an existing anti-cholesterol drug that promotes the disposal of mitochondria, as a potential new therapy for the treatment of Parkinson's disease.
Study identifies three different bacteria involved in Lewy body dementia. The findings provide new biomarkers for diagnosing the disease, and potential new avenues for therapeutic development.
Researchers are utilizing the C. elegans worm to investigate the emerging theory that Parkinson's disease starts in the gut and spreads to the brain.
Children who experience frequent nightmares at age 11 are twice as likely to develop symptoms of cognitive impairment, and seven times more likely to develop Parkinson's disease by age 50.
Endophilin A1, a gene associated with an increased risk of Parkinson's disease also blocks the process by which the brain and body recycle waste.
Exposure to air pollution has previously been linked to an increased risk of Alzheimer's disease. Now, researchers provide preliminary data linking air pollution to an increased risk of Parkinson's disease. The new study, which considered geographical data and diagnosis rates for Parkinson's, revealed those who live in the Mississippi-Ohio River Valley are at particularly higher risk of being diagnosed with Parkinson's.
Non-surgical focused ultrasound treatments significantly improve movement, tremors, and other physical symptoms of Parkinson's disease, researchers report. Two-thirds of patients who received focused ultrasound reported improvements in symptoms for up to a year following treatment.
Study reveals how signals from the environment integrate with genetic information that influences the survival and health of neurons, providing new insights into how Parkinson's disease may develop. Findings reveal the TNK2 gene mutations lead to the degeneration of dopamine producing neurons, resulting in Parkinson's disease pathology.
Researchers report a greater concentration of alpha-synuclein aggregates was found in stool samples from Parkinson's patients who suffered isolated REM-sleep behavior disorder.
REM sleep behavior disorder, or parasomnia, affects more than 80 million people worldwide. The disorder causes sufferers to experience nightmare-like violent dreams. Sufferers act on their dreams while sleeping, often resulting in violent or dangerous sleep behaviors and injuries. Researchers propose new guidelines, including medical and pharmacological recommendations, to help curb symptoms of parasomnia and promote healthier sleep.
